Document is current
Any future updates will be listed below
-
Authors
Yu, Jingbo
Parasuraman, Shreekant
Paranagama, Dilan
Bai, Andrew
Naim, Ahmad
Dubinski, David
Mesa, Ruben
-
Funding
Funding for this research was provided by:
Incyte Corporation (NA)
- License Information
-
More Information
Article History
Received: 5 July 2017
Accepted: 29 March 2018
First Online: 13 April 2018
Ethics approval and consent to participate
: The study received approval from Quorum Review Institutional Review Board (Quorum Review File number 31458). All respondents provided informed written consent.
: Not applicable.
: JY, SP, DP, AB, AN, and DD are employees and stockholders of Incyte Corporation. RM received research funding from Incyte Corporation, Gilead, CTI, Promedior, and Celgene and served as a consultant for Ariad, Galena, and Novartis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
